nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—Condition aggravated—Temozolomide—melanoma	0.0376	0.107	CcSEcCtD
Fluocinonide—Cushing's syndrome—Carmustine—melanoma	0.0313	0.0892	CcSEcCtD
Fluocinonide—Skin striae—Bleomycin—melanoma	0.0256	0.073	CcSEcCtD
Fluocinonide—Folliculitis—Vemurafenib—melanoma	0.0214	0.0609	CcSEcCtD
Fluocinonide—Eruption—Dactinomycin—melanoma	0.0123	0.0352	CcSEcCtD
Fluocinonide—Folliculitis—Dactinomycin—melanoma	0.0121	0.0344	CcSEcCtD
Fluocinonide—Dry skin—Vemurafenib—melanoma	0.00893	0.0255	CcSEcCtD
Fluocinonide—Skin exfoliation—Bleomycin—melanoma	0.00776	0.0221	CcSEcCtD
Fluocinonide—Eruption—Docetaxel—melanoma	0.00742	0.0212	CcSEcCtD
Fluocinonide—Skin exfoliation—Carmustine—melanoma	0.00678	0.0193	CcSEcCtD
Fluocinonide—Skin exfoliation—Temozolomide—melanoma	0.00655	0.0187	CcSEcCtD
Fluocinonide—Erythema—Vemurafenib—melanoma	0.00587	0.0167	CcSEcCtD
Fluocinonide—Swelling—Carmustine—melanoma	0.00584	0.0167	CcSEcCtD
Fluocinonide—Nasal congestion—Temozolomide—melanoma	0.00547	0.0156	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00496	0.0142	CcSEcCtD
Fluocinonide—Infection—Vemurafenib—melanoma	0.00476	0.0136	CcSEcCtD
Fluocinonide—Nervous system disorder—Vemurafenib—melanoma	0.0047	0.0134	CcSEcCtD
Fluocinonide—Skin disorder—Vemurafenib—melanoma	0.00465	0.0133	CcSEcCtD
Fluocinonide—Dry skin—Temozolomide—melanoma	0.00456	0.013	CcSEcCtD
Fluocinonide—Skin exfoliation—Docetaxel—melanoma	0.00436	0.0124	CcSEcCtD
Fluocinonide—Hyperglycaemia—Carmustine—melanoma	0.00402	0.0115	CcSEcCtD
Fluocinonide—Hyperglycaemia—Temozolomide—melanoma	0.00388	0.0111	CcSEcCtD
Fluocinonide—Swelling—Docetaxel—melanoma	0.00375	0.0107	CcSEcCtD
Fluocinonide—Erythema—Bleomycin—melanoma	0.00356	0.0101	CcSEcCtD
Fluocinonide—Hypersensitivity—Vemurafenib—melanoma	0.00353	0.0101	CcSEcCtD
Fluocinonide—Pruritus—Vemurafenib—melanoma	0.00339	0.00966	CcSEcCtD
Fluocinonide—Erythema—Dactinomycin—melanoma	0.00332	0.00946	CcSEcCtD
Fluocinonide—Dizziness—Vemurafenib—melanoma	0.00317	0.00903	CcSEcCtD
Fluocinonide—Immune system disorder—Temozolomide—melanoma	0.00311	0.00888	CcSEcCtD
Fluocinonide—Erythema—Carmustine—melanoma	0.0031	0.00885	CcSEcCtD
Fluocinonide—Dry skin—Docetaxel—melanoma	0.00304	0.00866	CcSEcCtD
Fluocinonide—Rash—Vemurafenib—melanoma	0.00302	0.00861	CcSEcCtD
Fluocinonide—Dermatitis—Vemurafenib—melanoma	0.00302	0.00861	CcSEcCtD
Fluocinonide—Headache—Vemurafenib—melanoma	0.003	0.00856	CcSEcCtD
Fluocinonide—Erythema—Temozolomide—melanoma	0.003	0.00855	CcSEcCtD
Fluocinonide—Nasopharyngitis—Docetaxel—melanoma	0.00296	0.00845	CcSEcCtD
Fluocinonide—Infection—Bleomycin—melanoma	0.00288	0.00822	CcSEcCtD
Fluocinonide—Infection—Dactinomycin—melanoma	0.00269	0.00767	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00254	0.00723	CcSEcCtD
Fluocinonide—Infection—Carmustine—melanoma	0.00252	0.00718	CcSEcCtD
Fluocinonide—Pain—Bleomycin—melanoma	0.00248	0.00708	CcSEcCtD
Fluocinonide—Infection—Temozolomide—melanoma	0.00243	0.00694	CcSEcCtD
Fluocinonide—Nervous system disorder—Temozolomide—melanoma	0.0024	0.00685	CcSEcCtD
Fluocinonide—Skin disorder—Temozolomide—melanoma	0.00238	0.00678	CcSEcCtD
Fluocinonide—Pain—Dactinomycin—melanoma	0.00231	0.0066	CcSEcCtD
Fluocinonide—Pain—Carmustine—melanoma	0.00217	0.00618	CcSEcCtD
Fluocinonide—Hypersensitivity—Bleomycin—melanoma	0.00214	0.0061	CcSEcCtD
Fluocinonide—Pain—Temozolomide—melanoma	0.00209	0.00597	CcSEcCtD
Fluocinonide—Immune system disorder—Docetaxel—melanoma	0.00207	0.0059	CcSEcCtD
Fluocinonide—Pruritus—Bleomycin—melanoma	0.00205	0.00586	CcSEcCtD
Fluocinonide—Erythema—Docetaxel—melanoma	0.00199	0.00569	CcSEcCtD
Fluocinonide—Hypersensitivity—Dactinomycin—melanoma	0.00199	0.00569	CcSEcCtD
Fluocinonide—Hypersensitivity—Carmustine—melanoma	0.00187	0.00532	CcSEcCtD
Fluocinonide—Rash—Bleomycin—melanoma	0.00183	0.00522	CcSEcCtD
Fluocinonide—Dermatitis—Bleomycin—melanoma	0.00183	0.00521	CcSEcCtD
Fluocinonide—Hypersensitivity—Temozolomide—melanoma	0.0018	0.00514	CcSEcCtD
Fluocinonide—Pruritus—Temozolomide—melanoma	0.00173	0.00494	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—melanoma	0.00171	0.00266	CbGpPWpGaD
Fluocinonide—Rash—Dactinomycin—melanoma	0.00171	0.00487	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.00169	0.00264	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00169	0.00481	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—TAS2R60—melanoma	0.00168	0.00262	CbGpPWpGaD
Fluocinonide—Dizziness—Carmustine—melanoma	0.00167	0.00478	CcSEcCtD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—melanoma	0.00167	0.0026	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KISS1—melanoma	0.00163	0.00254	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00163	0.00254	CbGpPWpGaD
Fluocinonide—Dizziness—Temozolomide—melanoma	0.00162	0.00462	CcSEcCtD
Fluocinonide—Infection—Docetaxel—melanoma	0.00162	0.00461	CcSEcCtD
Fluocinonide—Rash—Carmustine—melanoma	0.0016	0.00456	CcSEcCtD
Fluocinonide—Nervous system disorder—Docetaxel—melanoma	0.0016	0.00455	CcSEcCtD
Fluocinonide—Dermatitis—Carmustine—melanoma	0.0016	0.00455	CcSEcCtD
Fluocinonide—Headache—Carmustine—melanoma	0.00159	0.00453	CcSEcCtD
Fluocinonide—Skin disorder—Docetaxel—melanoma	0.00158	0.00451	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CXCR1—melanoma	0.00158	0.00246	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MC1R—melanoma	0.00156	0.00243	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.00155	0.00241	CbGpPWpGaD
Fluocinonide—Rash—Temozolomide—melanoma	0.00154	0.0044	CcSEcCtD
Fluocinonide—Dermatitis—Temozolomide—melanoma	0.00154	0.0044	CcSEcCtD
Fluocinonide—Headache—Temozolomide—melanoma	0.00153	0.00437	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.00152	0.00237	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.0015	0.00234	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—HIF1A—melanoma	0.0015	0.00234	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM1—melanoma	0.00149	0.00233	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR7—melanoma	0.00149	0.00233	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—EDN1—melanoma	0.00149	0.00232	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP17A1—melanoma	0.00149	0.189	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL10—melanoma	0.00147	0.00229	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00147	0.00229	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CSF2—melanoma	0.00145	0.00226	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL4—melanoma	0.00143	0.00223	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—melanoma	0.00141	0.0022	CbGpPWpGaD
Fluocinonide—Pain—Docetaxel—melanoma	0.00139	0.00397	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00139	0.00217	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.00138	0.00215	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.00137	0.00214	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00136	0.00212	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RHOB—melanoma	0.00136	0.00212	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—melanoma	0.00136	0.00211	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—EDN1—melanoma	0.00135	0.00211	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.00134	0.00209	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00133	0.00207	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00131	0.00205	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.00131	0.00204	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—HLA-A—melanoma	0.00129	0.00202	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00128	0.002	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00128	0.002	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—melanoma	0.00128	0.00199	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00127	0.00199	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL1—melanoma	0.00127	0.00198	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLCB4—melanoma	0.00127	0.00198	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—melanoma	0.00126	0.00196	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP1—melanoma	0.00125	0.00195	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—HIF1A—melanoma	0.00124	0.00193	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCR2—melanoma	0.00124	0.00193	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RAC2—melanoma	0.00122	0.0019	CbGpPWpGaD
Fluocinonide—Dexamethasone—NOS2—melanoma	0.00121	0.154	CrCbGaD
Fluocinonide—Hypersensitivity—Docetaxel—melanoma	0.0012	0.00342	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—WNT5A—melanoma	0.0012	0.00187	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CUL3—melanoma	0.0012	0.00186	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TRRAP—melanoma	0.0012	0.00186	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKR1B10—melanoma	0.00116	0.00181	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.00116	0.0018	CbGpPWpGaD
Fluocinonide—Pruritus—Docetaxel—melanoma	0.00115	0.00328	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—NOTCH1—melanoma	0.00114	0.00178	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.00114	0.00177	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—APC—melanoma	0.00112	0.00174	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.0011	0.00172	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.00109	0.00171	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.00109	0.0017	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—F2RL1—melanoma	0.00108	0.00169	CbGpPWpGaD
Fluocinonide—Dizziness—Docetaxel—melanoma	0.00108	0.00307	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.00107	0.00167	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.00106	0.00166	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—F2R—melanoma	0.00105	0.00164	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.00104	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00104	0.00162	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.00103	0.00161	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP1B1—melanoma	0.00103	0.131	CrCbGaD
Fluocinonide—Rash—Docetaxel—melanoma	0.00103	0.00293	CcSEcCtD
Fluocinonide—Dermatitis—Docetaxel—melanoma	0.00103	0.00292	CcSEcCtD
Fluocinonide—Headache—Docetaxel—melanoma	0.00102	0.00291	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—EDNRB—melanoma	0.00102	0.00159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM3—melanoma	0.00102	0.00159	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.001	0.00156	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SOCS1—melanoma	0.000998	0.00156	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000991	0.00154	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000983	0.00153	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KISS1—melanoma	0.000964	0.0015	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GAB2—melanoma	0.000962	0.0015	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GNA11—melanoma	0.000962	0.0015	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCR1—melanoma	0.000934	0.00146	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SKI—melanoma	0.000934	0.00146	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—ABCB1—melanoma	0.000922	0.117	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—MC1R—melanoma	0.00092	0.00143	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCR4—melanoma	0.000904	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000903	0.00141	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GNAQ—melanoma	0.000894	0.00139	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.000885	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR7—melanoma	0.000882	0.00137	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM1—melanoma	0.000882	0.00137	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000874	0.00136	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—E2F1—melanoma	0.000866	0.00135	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IFNG—melanoma	0.000864	0.00135	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CLNS1A—melanoma	0.000861	0.00134	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SUFU—melanoma	0.000859	0.00134	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT3—melanoma	0.000825	0.00129	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	0.000803	0.00125	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—FAS—melanoma	0.000802	0.00125	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RHOB—melanoma	0.000802	0.00125	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BCL2L11—melanoma	0.000802	0.00125	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	0.000784	0.00122	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	0.000774	0.00121	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HDAC6—melanoma	0.000771	0.0012	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—melanoma	0.000767	0.0012	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	0.000761	0.00119	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	0.000758	0.00118	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	0.000757	0.00118	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—HIF1A—melanoma	0.000754	0.00118	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SKI—melanoma	0.000754	0.00117	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCND1—melanoma	0.000748	0.00117	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	0.000741	0.00115	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000738	0.00115	CbGpPWpGaD
Fluocinonide—Methylprednisolone—ABCB1—melanoma	0.000735	0.0935	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—CXCR2—melanoma	0.000731	0.00114	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL8—melanoma	0.00073	0.00114	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—melanoma	0.000729	0.0928	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—melanoma	0.000726	0.00113	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—PTEN—melanoma	0.000722	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAC2—melanoma	0.000719	0.00112	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—WNT5A—melanoma	0.000708	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFC—melanoma	0.000708	0.0011	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	0.000708	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDN1—melanoma	0.000693	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CSF2—melanoma	0.000678	0.00106	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	0.000676	0.00105	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000652	0.00102	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCA—melanoma	0.00065	0.00101	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000644	0.001	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—melanoma	0.000641	0.001	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	0.000638	0.000994	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAP2K2—melanoma	0.000635	0.00099	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	0.000633	0.000987	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—F2R—melanoma	0.000621	0.000969	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—RB1—melanoma	0.000614	0.000957	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IGF1—melanoma	0.000608	0.000949	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.000603	0.00094	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RAC1—melanoma	0.000602	0.000939	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDNRB—melanoma	0.000602	0.000938	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—melanoma	0.0006	0.000935	CbGpPWpGaD
Fluocinonide—Betamethasone—PTGS2—melanoma	0.000597	0.076	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NPPA—melanoma	0.00059	0.000919	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTK2B—melanoma	0.000584	0.000911	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GAB2—melanoma	0.000568	0.000886	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GNA11—melanoma	0.000568	0.000886	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FLT1—melanoma	0.000566	0.000882	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000544	0.000847	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCR4—melanoma	0.000534	0.000833	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HDAC2—melanoma	0.000534	0.000833	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FOXO4—melanoma	0.000534	0.000833	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000534	0.000832	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GNAQ—melanoma	0.000528	0.000824	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000517	0.000806	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—melanoma	0.000509	0.000793	CbGpPWpGaD
Fluocinonide—Betamethasone—ABCB1—melanoma	0.000508	0.0646	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—SYK—melanoma	0.000497	0.000774	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000493	0.000768	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGFR—melanoma	0.000488	0.00076	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT3—melanoma	0.000488	0.00076	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ITGAV—melanoma	0.000488	0.00076	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CTNNB1—melanoma	0.000451	0.000704	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SOCS1—melanoma	0.000451	0.000704	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.000451	0.000703	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAP2K1—melanoma	0.00045	0.000702	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—S100B—melanoma	0.00045	0.000702	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CD—melanoma	0.000447	0.000697	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CDKN1A—melanoma	0.000441	0.000687	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.000434	0.000677	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB4—melanoma	0.000431	0.000671	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN2B—melanoma	0.000427	0.000665	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000423	0.000659	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CD86—melanoma	0.000413	0.000644	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDN1—melanoma	0.00041	0.000639	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000405	0.000631	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CSF2—melanoma	0.0004	0.000624	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF1—melanoma	0.0004	0.000624	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.000397	0.000619	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—melanoma	0.000394	0.000613	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—E2F1—melanoma	0.000392	0.000611	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00039	0.000608	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CB—melanoma	0.00039	0.000608	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFRA—melanoma	0.000388	0.000604	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ITGB3—melanoma	0.000384	0.000598	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRKCA—melanoma	0.000384	0.000598	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000378	0.00059	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPP1—melanoma	0.000376	0.000587	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAP2K2—melanoma	0.000375	0.000585	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL8—melanoma	0.000375	0.000584	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00037	0.000577	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPS3—melanoma	0.000369	0.000575	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000367	0.000572	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SNRPE—melanoma	0.000363	0.000566	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SKI—melanoma	0.000363	0.000566	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2—melanoma	0.000358	0.000558	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TERT—melanoma	0.000357	0.000556	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAC1—melanoma	0.000356	0.000555	CbGpPWpGaD
Fluocinonide—Dexamethasone—PTGS2—melanoma	0.000347	0.0442	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.000345	0.000537	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000344	0.000535	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIF1A—melanoma	0.000341	0.000532	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—melanoma	0.000341	0.000531	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000336	0.000524	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KDR—melanoma	0.000326	0.000509	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FN1—melanoma	0.000314	0.00049	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH1—melanoma	0.000307	0.000479	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CD80—melanoma	0.000301	0.00047	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KIT—melanoma	0.000301	0.000469	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APC—melanoma	0.000301	0.000469	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—melanoma	0.000301	0.000469	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NRAS—melanoma	0.000301	0.000469	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGF—melanoma	0.000297	0.000463	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCB1—melanoma	0.000295	0.0376	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000294	0.000459	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAPK3—melanoma	0.000288	0.000449	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NPPA—melanoma	0.000284	0.000443	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BRAF—melanoma	0.000283	0.000441	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1—melanoma	0.000275	0.000429	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—melanoma	0.000275	0.000428	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAPK1—melanoma	0.000274	0.000427	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EGFR—melanoma	0.000274	0.000427	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAP2K1—melanoma	0.000266	0.000415	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CD—melanoma	0.000264	0.000412	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KRAS—melanoma	0.000259	0.000403	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF2—melanoma	0.000253	0.000394	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.000248	0.000387	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CA—melanoma	0.000238	0.000371	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000238	0.00037	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MDM2—melanoma	0.000237	0.000369	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000234	0.000365	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB2—melanoma	0.000233	0.000364	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CB—melanoma	0.00023	0.000359	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL8—melanoma	0.000221	0.000345	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HRAS—melanoma	0.00022	0.000343	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1B—melanoma	0.000216	0.000337	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—melanoma	0.000212	0.00033	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—melanoma	0.000212	0.00033	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—melanoma	0.000211	0.000328	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HDAC2—melanoma	0.000208	0.000324	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCND1—melanoma	0.000206	0.000322	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CTNNB1—melanoma	0.000204	0.000318	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—melanoma	0.0002	0.000312	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1A—melanoma	0.0002	0.000311	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTEN—melanoma	0.000199	0.00031	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKB1—melanoma	0.000198	0.000309	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—melanoma	0.000194	0.000303	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—melanoma	0.00018	0.00028	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—melanoma	0.000178	0.000278	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRAS—melanoma	0.000178	0.000277	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK3—melanoma	0.00017	0.000265	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CDKN2B—melanoma	0.000166	0.000259	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—melanoma	0.000165	0.000258	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK1—melanoma	0.000162	0.000252	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGFR—melanoma	0.000162	0.000252	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—VDR—melanoma	0.000162	0.000252	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KRAS—melanoma	0.000153	0.000238	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PRKCA—melanoma	0.000149	0.000233	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ERCC2—melanoma	0.000148	0.000231	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CA—melanoma	0.00014	0.000219	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—melanoma	0.000136	0.000212	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—melanoma	0.000134	0.000208	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRAS—melanoma	0.00013	0.000203	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—melanoma	0.000124	0.000194	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH1—melanoma	0.000119	0.000186	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—melanoma	0.000115	0.000179	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—melanoma	0.000113	0.000176	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MAPK3—melanoma	6.61e-05	0.000103	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—melanoma	6.43e-05	0.0001	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—melanoma	4.46e-05	6.95e-05	CbGpPWpGaD
